⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

Official Title: Lanreotide 120 mg Effectiveness in Subjects With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice

Study ID: NCT03947762

Interventions

Study Description

Brief Summary: The purpose of the protocol is to estimate the progression-free survival (PFS) rate in subjects diagnosed with PanNET, according to investigator assessment, at 24 months after treatment initiation with lanreotide 120 mg every 28 days.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

IPO Coimbra, Coimbra, , Portugal

IPO Lisboa, Lisboa, , Portugal

Hospital São João, Porto, , Portugal

Hospital General de Alicante, Alicante, , Spain

Hospital Torrecardenas, Almería, , Spain

Hospital Universitario de Badajoz, Badajoz, , Spain

ICO Badalona, Badalona, , Spain

Hospital de Cruces, Baracaldo, , Spain

Hospital Universitario Vall Hebrón, Barcelona, , Spain

Hospital Santa Creu I Sant Pau, Barcelona, , Spain

Hospital Basurto, Bilbao, , Spain

Hospital Universitario de Burgos, Burgos, , Spain

Hospital Universitario Puerto Real, Cadiz, , Spain

Hospital General Ciudad Real, Ciudad Real, , Spain

Hospital San Pedro de Alcántara, Cáceres, , Spain

Hospital Universitario Reina Sofia, Córdoba, , Spain

Hospital Donostia, Donostia, , Spain

Hospital Virgen de las Nieves, Granada, , Spain

ICO Bellvitge, Hospitalet de Llobregat, , Spain

Hospital Juan Ramón Jimenez, Huelva, , Spain

Hospital Can Misses, Ibiza, , Spain

Hospital de Jerez, Jerez De La Frontera, , Spain

Hospital U. de Gran Canaria Negrín, Las Palmas De Gran Canaria, , Spain

Hospital Clínico U. Virgen de la Arrixaca, Murcia, , Spain

Hospital Morales Meseguer, Murcia, , Spain

Hospital Virgen de La Victoria, Málaga, , Spain

Hospital Santa María Nai, Ourense, , Spain

Hospital Universitario Central de Asturias, Oviedo, , Spain

Hospital Son Espases, Palma De Mallorca, , Spain

Hospital de Navarra, Pamplona, , Spain

Hospital Sant Joan de Reus, Reus, , Spain

Corporació Sanitària Parc Taulí, Sabadell, , Spain

Hospital Clínico de Salamanca, Salamanca, , Spain

Hospital U. Nuestra Señora de Candelaria, Santa Cruz De Tenerife, , Spain

Hospital Marqués de Valdecillas, Santander, , Spain

Hospital Conxo, Santiago De Compostela, , Spain

Hospital General de Segovia, Segovia, , Spain

Hospital Virgen Macarena, Sevilla, , Spain

Hs. Virgen del Rocio, Sevilla, , Spain

Hospital Mutua Terrassa, Terrassa, , Spain

Hospital Virgen de la Salud Toledo, Toledo, , Spain

Hospital General de Valencia, Valencia, , Spain

Hospital Universitario y Politécnico La Fe, Valencia, , Spain

Hospital Álvaro Cunqueiro, Vigo, , Spain

Hospital Lozano Blesa, Zaragoza, , Spain

Hospital Miguel Servet, Zaragoza, , Spain

Contact Details

Name: Ipsen Medical Director

Affiliation: Ipsen

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: